Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

This project aims to document and analyse - with a three-fold anthropological, psychosocial and economical approach - the consequences of the geographical distance from mainland France on the alloSCT on both patients, their caregivers and the healthcare system. It is organised in 3 working packages (WP).

Eligibility criteria

Qualifiers

patients diagnosed with hematological malignancy (myeloid acute leukemia, lymphoid acute leukemia, non-hodgkin lymphoma, Hodgkin disease, or myelodysplasic syndrome

candidate to an allogeneic hematopoietic stem cell transplantation in mainland France ;

Residing in Reunion Island

Age >18 year old;

Disqualifiers

Opposition to participation and collection of their data

Person deprived of liberty by judicial or administrative decision, and person subject to legal protection (guardianship or curators)

Trial design

Treatments tested in this trial

  • questionnaire

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators